Zobid D 50 Tablet DT

Zobid D 50 Tablet DT is designed as a dispersible tablet to facilitate rapid onset of action and ease of administration, especially for patients who have difficulty swallowing conventional tablets. The recommended dosage should be adhered to strictly to minimize the risk of adverse effects, which may include gastrointestinal discomfort, nausea, dyspepsia, and, in rare cases, more serious complications such as gastrointestinal bleeding or cardiovascular events.

It is contraindicated in patients with known hypersensitivity to diclofenac, aspirin, or other NSAIDs, and in those with active peptic ulcer disease or severe hepatic, renal, or cardiac impairment. Caution is advised in patients with a history of asthma or allergic reactions. Zobid D 50 Tablet DT should be used under medical supervision, with regular monitoring for efficacy and safety.